niftify.in

Business Standard

No plans to list diagnostic arm Agilus Diagnostics: IHH Healthcare

Engaging with regulator on open offer for 26.1% stake in Fortis

Business Standard

No plans to list diagnostic arm Agilus Diagnostics: IHH Healthcare

Engaging with regulator on open offer for 26.1% stake in Fortis

CNBC TV18

Will the Agilus Diagnostics IPO be revived? IHH Healthcare CEO answers

Instead, IHH has decided that Agilus will become a subsidiary of Fortis Healthcare with the company focusing on integrating its diagnostic operations with its hospital services, ensuring a comprehensive healthcare ecosystem.

CNBC TV18

Fortis Healthcare Open Offer: IHH Healthcare shares important updates on timeline and pricing

The IHH Healthcare board, in December 2018, had announced an Open Offer price of ₹170 per share to acquire a majority stake in Fortis Healthcare. However, that open offer was put on hold by the Supreme Court.

The Economic Times

IHH Health eyes acquisitions to grow business: CEO Prem Kumar Nair

IHH Healthcare plans to double its bed capacity in India to 10,000 beds over the next 4-5 years through brownfield expansion and acquisitions. The group aims to be among the top three healthcare providers in India, expanding into tier-2 cities while maintaining dual brands Fortis and Gleneagles.

The Economic Times

Fortis seeks CCI nod to buy 31.52% more in diagnostics subsidiary Agilus

Fortis Healthcare has sought approval from the Competition Commission of India to acquire an additional 31.52% stake in its diagnostics arm, Agilus, raising its shareholding to 89.2%. The deal, valued at ₹1,780 crore, involves buying stakes from private equity players. Additionally, Aquilo House Pte seeks approval to acquire a 26.47% stake in Aavas Financiers.

The Economic Times

Fortis designates Prem Kumar Nair as Vice-Chairman

He was appointed Group Chief Executive Officer of IHH Healthcare on October 1, 2023.

The Economic Times

Fortis, Apollo, Medanta, and Max lead the charge in bidding war for Jaypee Healthcare

Fortis Healthcare, Apollo Hospitals, Medanta, and Max Healthcare are among companies interested in acquiring Jaypee Healthcare, a subsidiary of Jaypee Infratech in Noida with a total debt of about Rs 1,000 crore.